Return to top
rfxcel Announces EPCIS Center of Excellence to Enable DSCSA Serialization Requirements
rfxcel Announces EPCIS Center of Excellence to Enable DSCSA Serialization Requirements

Share on

Date

10 December 2021

rfxcel Announces EPCIS Center of Excellence to Enable DSCSA Serialization Requirements

The goal is to accelerate the rollout of serialized data in advance of the 2023 deadline

Antares Vision Group and rfxcel have announced an EPCIS Center of Excellence (COE) to help the pharmaceutical industry prepare for U.S. Drug Supply Chain Security Act (DSCSA) serialization requirements that will take effect in less than two years.


GREAT NEWS! 

Discover the Antares Vision Radio, click here to listen to this article:

English Version - Italian Version


COE goals to be achieved by November 27, 2023:

The COE is a dedicated group of solution providers that will work with the industry to accelerate the rollout of serialized data and ensure it is exchanged properly before the November 27, 2023, deadline.

U.S. Drug Supply Chain Security Act (DSCSA) rfxcel

The DSCSA regulations require supply chain partners to share unit-level product data electronically in a secure, interoperable manner. This data includes detailed transaction information and product identifiers, which include a unique serial number. Right now, EPCIS — Electronic Product Code Information Services — is the most widely recognized international standard that will allow stakeholders to meet these requirements.

 

“The EPCIS COE is an industry-wide undertaking that relies on the knowledge and expertise of every member – rfxcel CEO Glenn Abood said –. The serialization deadline is just two years away, and rfxcel is excited to announce the COE and to be working with our peers to ensure the success of the DSCSA by meeting the requirements for accurate, high-quality data”.

 

rfxcel, which first introduced the COE at a Healthcare Distribution Alliance Quarterly Update on September 27, will provide regular updates about the group’s activities and progress on its website.

Comments

No comments have been posted yet. Please feel free to comment first!

Leave or Reply a comment for this article

preloader